New targets for therapy: antigen identification in adults with B-cell acute lymphoblastic leukaemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0851
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
New targets for therapy: antigen identification in adults with B-cell acute lymphoblastic leukaemia ; day:22 ; month:1 ; year:2020 ; pages:1-11
Cancer immunology immunotherapy ; (22.1.2020), 1-11
- Creator
-
Jordaens, Stephanie
Cooksey, Leah
Freire Boullosa, Laurie
Van Tendeloo, Viggo
Smits, Evelien
Mills, Ken I.
Orchard, Kim H.
Guinn, Barbara
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-020-02484-0
- URN
-
urn:nbn:de:101:1-2020042401012358391653
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jordaens, Stephanie
- Cooksey, Leah
- Freire Boullosa, Laurie
- Van Tendeloo, Viggo
- Smits, Evelien
- Mills, Ken I.
- Orchard, Kim H.
- Guinn, Barbara
- SpringerLink (Online service)
Other Objects (12)
NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia
Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia
VEGF - a novel therapeutic target in central nervous system acute lymphoblastic leukaemia
Uncommon manifestations of acute lymphoblastic leukaemia (ALL)
The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukaemia progression via CXCR5-CXCL13
Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia
Characterisation of FLT3 alterations in childhood acute lymphoblastic leukaemia
Correction to: Pegaspargase: A Review in Acute Lymphoblastic Leukaemia
Molecular processes involved in B cell acute lymphoblastic leukaemia
TARGET based m6A methylation-related genes predict prognosis relapsed B-cell acute lymphoblastic leukemia
Temporal changes of the incidence of childhood B-cell precursor acute lymphoblastic leukaemia in Germany during the COVID-19 pandemic
Chromosomal instability in the development of childhood acute lymphoblastic leukaemia
NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia
Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia
VEGF - a novel therapeutic target in central nervous system acute lymphoblastic leukaemia
Uncommon manifestations of acute lymphoblastic leukaemia (ALL)
The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukaemia progression via CXCR5-CXCL13
Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia
Characterisation of FLT3 alterations in childhood acute lymphoblastic leukaemia
Correction to: Pegaspargase: A Review in Acute Lymphoblastic Leukaemia
Molecular processes involved in B cell acute lymphoblastic leukaemia
TARGET based m6A methylation-related genes predict prognosis relapsed B-cell acute lymphoblastic leukemia
Temporal changes of the incidence of childhood B-cell precursor acute lymphoblastic leukaemia in Germany during the COVID-19 pandemic
Chromosomal instability in the development of childhood acute lymphoblastic leukaemia
NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia
Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia
VEGF - a novel therapeutic target in central nervous system acute lymphoblastic leukaemia
Uncommon manifestations of acute lymphoblastic leukaemia (ALL)
The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukaemia progression via CXCR5-CXCL13
Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia
Characterisation of FLT3 alterations in childhood acute lymphoblastic leukaemia
Correction to: Pegaspargase: A Review in Acute Lymphoblastic Leukaemia
Molecular processes involved in B cell acute lymphoblastic leukaemia
TARGET based m6A methylation-related genes predict prognosis relapsed B-cell acute lymphoblastic leukemia
Temporal changes of the incidence of childhood B-cell precursor acute lymphoblastic leukaemia in Germany during the COVID-19 pandemic